Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ RALBP1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5144683
Description
Immunogen sequence: PPDVVSDDEK DHGKKKGKFK KKEKRTEGYA AFQEDSSGDE AESPSKMKRS KGIHVFKKPS FSKKKEKDFK IKEKPKEEKH KEEKHKEEKH KEKKSKDLTA ADVVKQWKEK KKKKKPIQEP EVPQIDVPNL KP Antigen sequence identity: Mouse 95%; Rat 95%.
Can specifically activate hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. Mediates ATP-dependent transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX) and is the major ATP-dependent transporter of glutathione conjugates of electrophiles (GS-E) and DOX in erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. Serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with CDC2 to switch off endocytosis, One of its substrates would be EPN1/Epsin.
Specifications
RALBP1 | |
Polyclonal | |
Unconjugated | |
RALBP1 | |
76 kDa Ral-interacting protein; Cytocentrin; dinitrophenyl S-glutathione ATPase; DNP-SG ATPase; ralA binding protein 1; ralA-binding protein 1; RALBP1; Ral-interacting protein 1; RIP; RIP1; RLIP1; RLIP76 | |
Rabbit | |
Affinity chromatography | |
RUO | |
10928 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid | |
IgG |
Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q15311 | |
RALBP1 | |
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence. Antigen range: 57-188. Recombinant protein control fragment (Product #RP-109972). | |
100 μL | |
Primary | |
Human | |
Antibody | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction